• 1
    Peers F, Bosch X, Kaldor J, Linsell A, Pleijmen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer 1987; 39: 54553.
  • 2
    Yeh F-S, Yu M C, Mo C-C, Luo S, Tong M J, Henderson B E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989; 49: 25069.
  • 3
    Sell S, Hunt J M, Dunsford H A, Chisari F V. Synergy between hepatitis B virus expression and chemical hepatocarcinogenesis in transgenic mice. Cancer Res 1991; 51L: 127885.
  • 4
    Bannasch P, Khoshkou N I, Hacker H J, et al. Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks. Cancer Res 1995; 55: 331830.
  • 5
    De Flora S, Hietane E, Bartsch H, et al. Enhanced metabolic activation of chemical hepatocarcinogenesis in woodchucks infected with woodchuck hepatitis virus. Carcinogenesis 1989; 10: 1099106.
  • 6
    Gemechu-Hatewu M, Platt K-L, Oesch F, Hacker H J, Bannasch P, Steinberg P. Metabolic activation of aflatoxin B1 to aflatoxin B1-8,9-epoxide in woodchucks undergoing chronic active hepatitis. Int J Cancer 1997; 73: 58791.
  • 7
    Tennant B C, Hornbuckle W E, Yeager A E, et al. Effects of aflatoxin B1 on experimental woodchuck hepatitis virus infection and hepatocellular carcinomas. In: HollingerF B, LemonS M, MargolisH, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams and Wilkins, 1990; 599600.
  • 8
    IARC. Hepatitis B virus. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 59. Lyon: IARC, 1994; 45164.
  • 9
    Cova L, Wild C P, Mehrotra R, et al. Contribution of aflatoxin B1 and duck hepatitis B virus in the induction of liver tumors in ducks. Cancer Res 1990; 50: 215663.
  • 10
    Qian G S, Ross R K, Yu M C, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994; 3: 310.
  • 11
    Ross R K, Yuan J M, Yu M C, et al. Urinary aflatoxin biomarkers and the risk of hepatocellular carcinoma. Lancet 1992; 339: 9436.
  • 12
    Wang L-Y, Hatch M, Chen C-J, et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Br J Cancer 1996; 67: 62030.
  • 13
    Lunn R M, Zhang Y-J, Wang L-Y, et al. Mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 1997; 57: 34717.
  • 14
    Sun Z, Lu P, Gail M H, et al. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 1999; 30: 37983.
  • 15
    Ming L, Thorgeirsson S S, Gail M H, et al. Dominant role of hepatitis B virus and co-factor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 2002; 36: 121420.
  • 16
    Yu M-W, Lien J-P, Chiu Y-H, Santella R M, Liaw Y-F, Chen C-J. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol 1997; 27: 12030.
  • 17
    Sun C-A, Wang L-Y, Chen C-J, et al. Genetic polymorphisms of glutathione-S-transferases M1 and T1 associated with susceptibility to aflatoxin-related carcinogenesis among chronic hepatitis B carriers: a nested case–control study in Taiwan. Carcinogenesis 2001; 22: 128994.
  • 18
    Chen C J, Zhang Y J, Lu S N, Santella R M. Afaltoxin-B1-adducts in smeared liver tissue of hepatocellular carcinoma patients. Hepatology 1992; 16: 11505.
  • 19
    Chen C-J, Yu M-W, Liaw Y-F, et al. Chronic hepatitis B carriers with null genotypes glutathione-S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 1996; 59: 12834.
  • 20
    McGlynn K A, Rosvold E A, Lustbader E D, et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 1995; 92: 23847.
  • 21
    Hsu I C, Metcalf R A, Sun T, Welsh J A, Wang N J, Harris C C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (London) 1991; 350: 4278.
  • 22
    Bressac B, Kew M C, Wands J R, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (London) 1991; 350: 42930.
  • 23
    Ozturk M, Bressac B, Pusieux A, et al. A p53 mutational hotspot in primary liver cancer is geographically localised to high aflatoxin areas of the world. Lancet 1991; 338: 2605.
  • 24
    Eaton D L, Gallagher E P. Mechanisms of aflatoxin carcinogenesis. Ann Rev Pharmacol Toxicol 1994; 34: 275301.
  • 25
    Sheu J-C, Huang G-T, Lee P-H, et al. Mutations of p53 in hepatocellular carcinomas in Taiwan. Cancer Res 1992; 52: 6098100.
  • 26
    Stern M C, Umbach D M, Yu M C, London S J, Zhang Z-Q, Taylor J A. Hepatitis B, aflatoxin B1, and p53 codon 249 mutation in hepatocellular carcinoma from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Cancer Epidemiol Biomarkers Prev 2001; 10: 61725.
  • 27
    Chemin I, Ohgaki H, Chisari F V, Wild C P. Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen. Liver 1999; 19: 817.
  • 28
    Allen S J, Wild C P, Wheeler J G, et al. Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans Roy Soc Trop Med Hyg 1992; 86: 42630.
  • 29
    Chen S-Y, Chen C-J, Chou S-R, et al. Association of aflatoxin B1-albumin adduct levels with hepatitis B surface antigen status among adolescents in Taiwan. Cancer Epidemiol Biomarkers Prev 2001; 10: 12236.
  • 30
    Turner P C, Mendy M, Whittle H, Fortuin M, Hall A J, Wild C P. Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop Med Int Health 2000; 5: 83741.
  • 31
    Groopman J D, Hall A J, Whittle H, et al. Molecular dosimetry of aflatoxin-N7 –guanine in human urine obtained in The Gambia. Cancer Epidemiol Biomarkers Prev 1992; 1: 2217.
  • 32
    Wang J S, Qian G S, Zarba A, et al. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and-negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1996; 5: 25361.
  • 33
    Chen S-Y, Chen C-J, Tsai W-Y, et al. Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione-S-transferase M1 and T1. Nutr Cancer 2000; 38: 17985.
  • 34
    Sun C-A, Wu D-M, Wang L-Y, Chen C-J, You S-L, Santella RM. Determinants of formation of aflatoxin-albumin adducts: a seven township study in Taiwan. Br J Cancer 2002; 87: 96670.
  • 35
    Kirby G, Chemin I, Montesano R, Chisari F V, Lang M A, Wild C P. Induction of specific cyotochrome p-450s involved in aflatoxin B1 metabolism in hepatitis B transgenic mice. Mol Carcinogenesis 1994; 11: 7480.
  • 36
    Wild C P, Fortuin M, Donato F, et al. Aflatoxin, liver enzymes and hepatitis B virus infection in Gambian children. Cancer Epidemiol Biomarkers Prev 1993; 2: 55561.
  • 37
    Chisari F V, Klopchin K, Moriyama T, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B transgenic mice. Cell 1989; 59: 114556.
  • 38
    Liu R H, Jacob J R, Hotchkiss J H, Cote P J, Gerin J L, Tennant B C. Woodchuck hepatitis virus surface antigen induces nitric oxide synthesis in hepatocytes: possible role in hepatocarcinogenesis. Carcinogenesis 1994; 15: 28757.
  • 39
    Ishima H, Bartsch H. Chronic infection and inflammatory processes as cancer risk factors: possible role for nitric oxide in carcinogenesis. Mutation Res 1994; 305: 25364.
  • 40
    Hussain S P, Aquilar F, Amstad P, Cerutti P. Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene 1994; 9: 227781.
  • 41
    Jia L, Wang X W, Harris C C. Hepatitis B virus×protein inhibits nucleotide excision repair. Int J Cancer 1999; 80: 8759.
  • 42
    Ahn J I, Jung E Y, Kwun H J, Lee C W, Sung Y C, Jang K L. Dual effects of hepatitis B virus × protein on the regulation of cell cycle depending on the status of cellular p53. J Gen Virol 2002; 83: 276572.
  • 43
    Madden C R, Finegold M J, Slagle B L. Altered DNA mutation spectrum in aflatoxin B1-treated transgenic mice that express the hepatitis B virus×protein. J Virol 2002; 76: 117704.